Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1547)	3/14/2000 8:53:00 PM
From: scaram(o)uche	Respond to of 4974

Dain Rauscher and Punk, Ziegel.... interesting, the names that are popping up next to RS et al....... Tuesday March 14, 6:24 pm Eastern Time Company Press Release Lynx Therapeutics, Inc. Files Registration Statement for Public Offering of Common Stock HAYWARD, Calif.--(BW HealthWire)--Mar. 14, 2000--Lynx Therapeutics, Inc. (Nasdaq:LYNX - news) announced today it has filed a registration statement with the Securities and Exchange Commission relating to a proposed public offering of 1,500,000 shares of common stock (plus up to 225,000 additional shares to cover over-allotments, if any), all of which will be offered by Lynx. The offering is being made through an underwriter group managed by Chase H&Q, Robertson Stephens, Dain Rauscher Wessels and Punk, Ziegel & Company. (snip)